ArticleScience advances2024

Surgical tumor-derived nanoplatform targets tumor-associated macrophage for personalized postsurgical cancer immunotherapy.

Gongxi Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.